Surat Phonsombat, MD
Urology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 15
- 3 carriers
- Offices
- 8
Offices
8 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
15 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Phonsombat’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
15 of 15 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A86907 · Current
Licensed to practise in California · since 2004 · expires 2028-04-30 · New York University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$179,268
Medicare paid this office $179,268 for 450 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Diagnostic exam of bladder and urethra using an endoscope | 104 | $36,198 | $246 |
| Return visit (30+ min) | 193 | $31,271 | $114 |
| Short return visit (20+ min) | 175 | $19,696 | $82 |
| New patient visit (45+ min) | 122 | $18,110 | $148 |
| Simple surgical subtotal removal of prostate using laparoscope | 11 | $5,502 | $500 |
See all 13 services
| Diagnostic exam of bladder and urethra using an endoscope | 104 | $36,198 | $246 |
| Return visit (30+ min) | 193 | $31,271 | $114 |
| Short return visit (20+ min) | 175 | $19,696 | $82 |
| New patient visit (45+ min) | 122 | $18,110 | $148 |
| Simple surgical subtotal removal of prostate using laparoscope | 11 | $5,502 | $500 |
| Ultrasound scan of pelvic region through rectum | 34 | $4,980 | $146 |
| Biopsy of prostate gland | 21 | $4,796 | $228 |
| Simple insertion of temporary bladder tube | 27 | $2,637 | $61 |
| Ultrasound measurement of bladder capacity after voiding | 143 | $2,487 | $12 |
| Insertion of stent in ureter using an endoscope | 17 | $2,350 | $102 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 106 | $1,816 | $15 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,396 | $116 |
| Review by radiologist of ureter or urethra image | 16 | $666 | $35 |
Procedures Medicare counted
| Prostate resection | 29 | More than 89% of doctors who do this |
Who their Medicare patients are
450 Original Medicare patients in 2024. Average age 76 · Women 22% · Also on Medicaid 9% · Health risk score 1.08. At or below the middle of the specialty; the typical urology clinician is at 1.36.
Conditions among them: High blood pressure 68% · Cancer 37% · Chronic kidney disease 28% · Diabetes 26% · Coronary heart disease 26% · Atrial fibrillation 20% · Heart failure 12% · Depression 12% · COPD 8% · Dementia 6% · Stroke 5%.
The office billed $869,459, Medicare allowed $234,159 and paid $179,268; for 1,486 services of 76 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 450 | 1,486 | 76 | 1.08 | $869,459 | $179,268 |
| 2023 | 457 | 1,396 | 76 | 1.16 | $815,596 | $179,927 |
| 2022 | 452 | 1,417 | 77 | 1.00 | $874,105 | $184,110 |
| 2021 | 429 | 1,325 | 77 | 1.12 | $689,718 | $159,667 |
| 2020 | 404 | 1,287 | 76 | 1.23 | $737,616 | $153,389 |
| 2019 | 392 | 1,374 | 76 | 1.20 | $782,392 | $146,415 |
| 2018 | 401 | 1,449 | 76 | 1.29 | $766,733 | $148,222 |
| 2017 | 377 | 1,302 | 75 | 1.29 | $643,275 | $134,584 |
| 2016 | 323 | 1,133 | 75 | 1.15 | $575,848 | $123,469 |
| 2015 | 328 | 1,103 | 76 | 1.28 | $531,009 | $117,229 |
| 2014 | 287 | 964 | 75 | 1.13 | $492,018 | $100,691 |
| 2013 | 239 | 813 | 74 | 1.22 | $454,102 | $89,860 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Diagnostic exam of bladder and urethra using an endoscope | 93 | $34,271 | $254 |
| Return visit (30+ min) | 195 | $32,815 | $117 |
| New patient visit (45+ min) | 130 | $19,304 | $148 |
| Short return visit (20+ min) | 172 | $17,839 | $81 |
| Ultrasound scan of pelvic region through rectum | 21 | $3,309 | $150 |
| Ultrasound measurement of bladder capacity after voiding | 163 | $2,782 | $12 |
| Insertion of stent in ureter using an endoscope | 13 | $2,049 | $108 |
| Simple insertion of temporary bladder tube | 23 | $2,004 | $56 |
| New patient visit (30+ min) | 11 | $1,095 | $100 |
| Review by radiologist of ureter or urethra image | 14 | $618 | $36 |
2022: 15 services
| Diagnostic exam of bladder and urethra using an endoscope | 111 | $40,043 | $257 |
| Return visit (30+ min) | 227 | $37,008 | $115 |
| New patient visit (45+ min) | 108 | $16,572 | $153 |
| Short return visit (20+ min) | 130 | $12,945 | $79 |
| Partial removal of prostate (retropubic) | 13 | $7,613 | $586 |
| Ultrasound scan of pelvic region through rectum | 39 | $5,975 | $153 |
| Biopsy of prostate gland | 24 | $5,531 | $230 |
| Ultrasound measurement of bladder capacity after voiding | 170 | $2,421 | $11 |
| Simple insertion of temporary bladder tube | 19 | $2,410 | $60 |
| Insertion of stent in ureter using an endoscope | 13 | $2,010 | $112 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 12 | $1,172 | $90 |
| New patient visit (30+ min) | 14 | $1,098 | $78 |
| Simple bladder irrigation and/or instillation | 11 | $845 | $70 |
| Short return visit | 17 | $741 | $41 |
| Imaging of urinary tract following injection of a contrast agent | 12 | $298 | $23 |
2021: 12 services
| Diagnostic exam of bladder and urethra using an endoscope | 99 | $32,488 | $252 |
| Return visit (30+ min) | 175 | $28,035 | $121 |
| New patient visit (45+ min) | 110 | $16,397 | $149 |
| Short return visit (20+ min) | 140 | $14,851 | $82 |
| Simple insertion of temporary bladder tube | 23 | $3,775 | $62 |
| Ultrasound scan of pelvic region through rectum | 18 | $3,058 | $153 |
| New patient visit (30+ min) | 26 | $2,865 | $110 |
| Ultrasound measurement of bladder capacity after voiding | 173 | $2,468 | $11 |
| Biopsy of prostate gland | 11 | $2,457 | $223 |
| Insertion of stent in ureter using an endoscope | 11 | $1,398 | $100 |
| Short return visit | 21 | $1,153 | $52 |
| Review by radiologist of ureter or urethra image | 11 | $442 | $37 |
2020: 14 services
| Diagnostic exam of bladder and urethra using an endoscope | 87 | $24,101 | $217 |
| Return visit (30+ min) | 136 | $17,517 | $96 |
| Short return visit (20+ min) | 167 | $15,520 | $66 |
| New patient visit (45+ min) | 83 | $11,770 | $142 |
| Ultrasound scan of pelvic region through rectum | 33 | $5,602 | $156 |
| Biopsy of prostate gland | 18 | $4,472 | $248 |
| New patient visit (30+ min) | 39 | $3,721 | $95 |
| Simple insertion of temporary bladder tube | 24 | $3,084 | $58 |
| Insertion of stent in ureter using an endoscope | 13 | $2,228 | $97 |
| Ultrasound measurement of bladder capacity after voiding | 130 | $1,966 | $11 |
| Telephone medical discussion with physician, 11-20 minutes | 20 | $1,336 | $67 |
| Short return visit | 22 | $1,072 | $43 |
| 3d radiographic procedure with computerized image postprocessing | 11 | $731 | $66 |
| Review by radiologist of ureter or urethra image | 11 | $455 | $38 |
2019: 13 services
| Diagnostic exam of bladder and urethra using an endoscope | 77 | $22,212 | $188 |
| Short return visit (20+ min) | 180 | $18,516 | $65 |
| Return visit (30+ min) | 122 | $15,634 | $95 |
| New patient visit (45+ min) | 75 | $11,040 | $147 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 14 | $9,506 | $679 |
| Simple insertion of temporary bladder tube | 28 | $5,063 | $59 |
| Ultrasound scan of pelvic region through rectum | 29 | $3,808 | $131 |
| New patient visit (30+ min) | 39 | $3,680 | $94 |
| Ultrasound measurement of bladder capacity after voiding | 161 | $3,235 | $13 |
| Biopsy of prostate gland | 11 | $2,608 | $237 |
| Insertion of stent in ureter using an endoscope | 15 | $2,565 | $112 |
| Short return visit | 15 | $850 | $40 |
| Imaging of urinary tract following injection of a contrast agent | 14 | $477 | $24 |
2018: 13 services
| Diagnostic exam of bladder and urethra using an endoscope | 91 | $20,931 | $157 |
| Short return visit (20+ min) | 199 | $18,486 | $61 |
| New patient visit (45+ min) | 70 | $10,026 | $143 |
| Return visit (30+ min) | 81 | $9,551 | $96 |
| New patient visit (30+ min) | 55 | $5,261 | $96 |
| Simple insertion of temporary bladder tube | 30 | $4,765 | $60 |
| Ultrasound measurement of bladder capacity after voiding | 158 | $3,956 | $16 |
| Biopsy of prostate gland | 12 | $2,582 | $215 |
| Ultrasound scan of pelvic region through rectum | 19 | $2,417 | $93 |
| Insertion of stent in ureter using an endoscope | 19 | $2,355 | $102 |
| Short return visit | 33 | $1,698 | $39 |
| Review by radiologist of ureter or urethra image | 12 | $354 | $24 |
| Imaging of urinary tract following injection of a contrast agent | 13 | $240 | $16 |
2017: 14 services
| Short return visit (20+ min) | 176 | $16,371 | $63 |
| Diagnostic exam of bladder and urethra using an endoscope | 73 | $14,509 | $156 |
| New patient visit (45+ min) | 63 | $9,221 | $146 |
| Return visit (30+ min) | 62 | $7,456 | $98 |
| New patient visit (30+ min) | 70 | $6,350 | $91 |
| Ultrasound measurement of bladder capacity after voiding | 151 | $4,243 | $19 |
| Simple insertion of temporary bladder tube | 28 | $3,669 | $56 |
| Biopsy of prostate gland | 14 | $3,353 | $240 |
| Ultrasound scan of pelvic region through rectum | 20 | $2,224 | $97 |
| Short return visit | 45 | $1,979 | $35 |
| Long return visit (40+ min) | 11 | $1,542 | $128 |
| Insertion of stent in ureter using an endoscope | 11 | $1,087 | $91 |
| Ultrasonic guidance for needle placement | 15 | $1,002 | $59 |
| Review by radiologist of ureter or urethra image | 13 | $306 | $24 |
2016: 15 services
| Diagnostic exam of bladder and urethra using an endoscope | 69 | $16,040 | $191 |
| Short return visit (20+ min) | 163 | $14,813 | $62 |
| New patient visit (45+ min) | 63 | $9,120 | $145 |
| Return visit (30+ min) | 52 | $6,080 | $95 |
| New patient visit (30+ min) | 44 | $4,042 | $92 |
| Ultrasound measurement of bladder capacity after voiding | 142 | $4,014 | $19 |
| Biopsy of prostate gland | 15 | $3,116 | $208 |
| Simple insertion of temporary bladder tube | 17 | $2,942 | $68 |
| Long return visit (40+ min) | 20 | $2,680 | $134 |
| Ultrasound scan of pelvic region through rectum | 25 | $2,196 | $84 |
| Short return visit | 34 | $1,622 | $41 |
| Insertion of stent in ureter using an endoscope | 11 | $1,010 | $72 |
| Ultrasonic guidance for needle placement | 14 | $766 | $55 |
| Review by radiologist of ureter or urethra image | 12 | $353 | $24 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 12 | $255 | $15 |
2015: 14 services
| Diagnostic exam of bladder and urethra using an endoscope | 59 | $16,581 | $202 |
| Short return visit (20+ min) | 154 | $15,051 | $67 |
| New patient visit (45+ min) | 76 | $11,550 | $152 |
| Return visit (30+ min) | 58 | $6,985 | $98 |
| Ultrasound measurement of bladder capacity after voiding | 132 | $4,103 | $20 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 11 | $4,021 | $335 |
| Simple insertion of temporary bladder tube | 29 | $3,575 | $69 |
| Long return visit (40+ min) | 20 | $3,043 | $138 |
| New patient visit (30+ min) | 28 | $2,817 | $101 |
| Short return visit | 31 | $1,578 | $37 |
| Ultrasound scan of pelvic region through rectum | 16 | $1,313 | $82 |
| Insertion of stent in ureter using an endoscope | 11 | $1,290 | $117 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 15 | $433 | $19 |
| Review by radiologist of ureter or urethra image | 15 | $379 | $24 |
2014: 12 services
| Diagnostic exam of bladder and urethra using an endoscope | 55 | $14,934 | $191 |
| New patient visit (45+ min) | 85 | $12,388 | $146 |
| Short return visit (20+ min) | 110 | $10,690 | $60 |
| Return visit (30+ min) | 54 | $6,608 | $93 |
| Ultrasound measurement of bladder capacity after voiding | 125 | $3,491 | $19 |
| New patient visit (30+ min) | 24 | $2,313 | $96 |
| Simple change of bladder tube | 11 | $1,782 | $81 |
| Short return visit | 32 | $1,686 | $36 |
| Insertion of stent in ureter using an endoscope | 13 | $1,394 | $82 |
| Long return visit (40+ min) | 11 | $1,336 | $121 |
| Simple insertion of temporary bladder tube | 14 | $1,238 | $62 |
| Ultrasound scan of pelvic region through rectum | 12 | $1,110 | $92 |
2013: 11 services
| Diagnostic exam of bladder and urethra using an endoscope | 49 | $15,321 | $187 |
| New patient visit (45+ min) | 80 | $11,359 | $142 |
| Short return visit (20+ min) | 88 | $7,937 | $61 |
| Return visit (30+ min) | 56 | $6,529 | $89 |
| Ultrasonic guidance for needle placement | 17 | $3,453 | $203 |
| Biopsy of prostate gland | 16 | $3,155 | $197 |
| Ultrasound measurement of bladder capacity after voiding | 100 | $2,857 | $19 |
| Simple insertion of temporary bladder tube | 14 | $1,919 | $64 |
| Short return visit | 40 | $1,714 | $36 |
| Ultrasound scan of pelvic region through rectum | 16 | $1,214 | $71 |
| New patient visit (30+ min) | 13 | $845 | $65 |
Drugs they prescribed that Part D paid
$60,728
Pharmacies billed $60,728 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (41 of 1,108) in 2024. Above the middle of the specialty; the typical urology clinician is at 2%.
1,073 generic and fewer than 11 brand-name prescriptions · $60,728 in drug cost · 174 antibiotic prescriptions to 106 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Myrbetriq | 26 | $33,488 | $1,288 |
| Tamsulosin | 437 | $7,803 | $18 |
| Oxybutynin Chloride Er | 101 | $2,502 | $25 |
| Finasteride | 140 | $1,848 | $13 |
| Methenamine Hippurate | 22 | $1,503 | $68 |
See all 16 drugs
| Myrbetriq | 26 | $33,488 | $1,288 |
| Tamsulosin | 437 | $7,803 | $18 |
| Oxybutynin Chloride Er | 101 | $2,502 | $25 |
| Finasteride | 140 | $1,848 | $13 |
| Methenamine Hippurate | 22 | $1,503 | $68 |
| Silodosin | 23 | $1,497 | $65 |
| Solifenacin | 19 | $387 | $20 |
| Alfuzosin Hcl Er | 12 | $352 | $29 |
| Hydrocodone-Acetaminophen | 41 | $340 | $8 |
| Nitrofurantoin Mono-Macro | 14 | $230 | $16 |
| Doxazosin Mesylate | 12 | $207 | $17 |
| Oxybutynin Chloride | 17 | $207 | $12 |
| Ciprofloxacin | 40 | $161 | $4 |
| Sulfamethoxazole-Trimethoprim | 61 | $151 | $2 |
| Cephalexin | 39 | $119 | $3 |
| Levofloxacin | 11 | $119 | $11 |
Year by year
| 2024 | 1,108 | 310 | 4% (41) | None | $60,728 |
| 2023 | 1,133 | 312 | 4% (45) | None | $68,742 |
| 2022 | 1,101 | 291 | 4% (43) | None | $59,958 |
| 2021 | 1,043 | 278 | 4% (40) | None | $63,492 |
| 2020 | 1,015 | 267 | 5% (48) | None | $50,859 |
| 2019 | 949 | 230 | 5% (43) | None | $55,293 |
| 2018 | 1,062 | 233 | 6% (61) | 6% | $55,138 |
| 2017 | 1,092 | 224 | 4% (45) | None | $68,371 |
| 2016 | 982 | 201 | 4% (36) | None | $54,759 |
| 2015 | 862 | 185 | 4% (37) | None | $50,342 |
| 2014 | 709 | 163 | 6% (43) | None | $40,548 |
| 2013 | 588 | 144 | 6% (34) | None | $31,332 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Myrbetriq | 34 | $37,767 | $1,111 |
| Tamsulosin | 383 | $10,604 | $28 |
| Oxybutynin Chloride Er | 168 | $7,092 | $42 |
| Finasteride | 151 | $2,733 | $18 |
| Oxybutynin Chloride | 39 | $973 | $25 |
| Doxazosin Mesylate | 27 | $513 | $19 |
| Hydrocodone-Acetaminophen | 44 | $364 | $8 |
| Alfuzosin Hcl Er | 16 | $249 | $16 |
| Cephalexin | 53 | $202 | $4 |
| Ciprofloxacin | 42 | $201 | $5 |
| Terazosin | 12 | $196 | $16 |
| Sulfamethoxazole-Trimethoprim | 45 | $175 | $4 |
2022: 16 drugs
| Myrbetriq | 37 | $28,974 | $783 |
| Tamsulosin | 353 | $8,571 | $24 |
| Oxybutynin Chloride Er | 128 | $5,482 | $43 |
| Finasteride | 169 | $3,487 | $21 |
| Oxybutynin Chloride | 57 | $1,294 | $23 |
| Bicalutamide | 19 | $851 | $45 |
| Silodosin | 11 | $663 | $60 |
| Solifenacin | 12 | $659 | $55 |
| Nitrofurantoin Mono-Macro | 18 | $526 | $29 |
| Doxazosin Mesylate | 12 | $442 | $37 |
| Hydrocodone-Acetaminophen | 42 | $387 | $9 |
| Cephalexin | 52 | $319 | $6 |
| Ciprofloxacin | 42 | $271 | $6 |
| Amoxicillin-Clavulanate Potass | 13 | $228 | $18 |
| Terazosin | 13 | $169 | $13 |
| Sulfamethoxazole-Trimethoprim | 43 | $168 | $4 |
2021: 14 drugs
| Myrbetriq | 47 | $35,683 | $759 |
| Tamsulosin | 327 | $6,977 | $21 |
| Oxybutynin Chloride Er | 165 | $6,593 | $40 |
| Finasteride | 153 | $3,544 | $23 |
| Oxybutynin Chloride | 51 | $1,406 | $28 |
| Bicalutamide | 11 | $802 | $73 |
| Doxazosin Mesylate | 13 | $574 | $44 |
| Silodosin | 11 | $542 | $49 |
| Nitrofurantoin Mono-Macro | 16 | $448 | $28 |
| Terazosin | 19 | $322 | $17 |
| Hydrocodone-Acetaminophen | 39 | $311 | $8 |
| Cephalexin | 53 | $171 | $3 |
| Ciprofloxacin | 38 | $132 | $3 |
| Sulfamethoxazole-Trimethoprim | 31 | $111 | $4 |
2020: 13 drugs
| Myrbetriq | 28 | $22,391 | $800 |
| Oxybutynin Chloride Er | 150 | $8,289 | $55 |
| Tamsulosin | 319 | $6,795 | $21 |
| Finasteride | 131 | $3,566 | $27 |
| Oxybutynin Chloride | 61 | $1,292 | $21 |
| Doxazosin Mesylate | 17 | $979 | $58 |
| Nitrofurantoin Mono-Macro | 32 | $851 | $27 |
| Alfuzosin Hcl Er | 18 | $678 | $38 |
| Bicalutamide | 15 | $555 | $37 |
| Hydrocodone-Acetaminophen | 47 | $403 | $9 |
| Sulfamethoxazole-Trimethoprim | 62 | $246 | $4 |
| Cephalexin | 37 | $92 | $2 |
| Ciprofloxacin | 35 | $89 | $3 |
2019: 12 drugs
| Myrbetriq | 33 | $19,960 | $605 |
| Tamsulosin | 322 | $6,322 | $20 |
| Oxybutynin Chloride Er | 121 | $6,051 | $50 |
| Finasteride | 153 | $3,296 | $22 |
| Oxybutynin Chloride | 36 | $981 | $27 |
| Doxazosin Mesylate | 13 | $656 | $50 |
| Hydrocodone-Acetaminophen | 42 | $389 | $9 |
| Terazosin | 17 | $382 | $22 |
| Nitrofurantoin Mono-Macro | 15 | $380 | $25 |
| Ciprofloxacin | 42 | $284 | $7 |
| Sulfamethoxazole-Trimethoprim | 50 | $186 | $4 |
| Cephalexin | 29 | $164 | $6 |
2018: 15 drugs
| Myrbetriq | 29 | $13,721 | $473 |
| Vesicare | 12 | $9,662 | $805 |
| Oxybutynin Chloride Er | 136 | $7,644 | $56 |
| Tamsulosin | 281 | $6,245 | $22 |
| Finasteride | 206 | $3,736 | $18 |
| Oxybutynin Chloride | 55 | $1,965 | $36 |
| Methenamine Hippurate | 12 | $1,134 | $94 |
| Doxazosin Mesylate | 16 | $762 | $48 |
| Dutasteride | 15 | $494 | $33 |
| Hydrocodone-Acetaminophen | 59 | $450 | $8 |
| Nitrofurantoin Mono-Macro | 17 | $385 | $23 |
| Terazosin | 25 | $332 | $13 |
| Cephalexin | 40 | $233 | $6 |
| Sulfamethoxazole-Trimethoprim | 54 | $212 | $4 |
| Ciprofloxacin | 48 | $181 | $4 |
2017: 15 drugs
| Vesicare | 31 | $16,541 | $534 |
| Myrbetriq | 29 | $10,105 | $348 |
| Oxybutynin Chloride Er | 164 | $8,351 | $51 |
| Tamsulosin | 271 | $6,406 | $24 |
| Finasteride | 186 | $3,335 | $18 |
| Oxybutynin Chloride | 55 | $1,734 | $32 |
| Dutasteride | 21 | $878 | $42 |
| Doxazosin Mesylate | 22 | $876 | $40 |
| Nitrofurantoin Mono-Macro | 24 | $487 | $20 |
| Ciprofloxacin | 76 | $327 | $4 |
| Hydrocodone-Acetaminophen | 45 | $264 | $6 |
| Terazosin | 24 | $258 | $11 |
| Bicalutamide | 15 | $237 | $16 |
| Sulfamethoxazole-Trimethoprim | 23 | $103 | $4 |
| Cephalexin | 23 | $88 | $4 |
2016: 15 drugs
| Vesicare | 49 | $17,746 | $362 |
| Tamsulosin | 293 | $5,725 | $20 |
| Oxybutynin Chloride Er | 110 | $4,710 | $43 |
| Dutasteride | 26 | $3,922 | $151 |
| Myrbetriq | 12 | $3,559 | $297 |
| Finasteride | 191 | $3,121 | $16 |
| Oxybutynin Chloride | 34 | $1,368 | $40 |
| Doxazosin Mesylate | 17 | $769 | $45 |
| Nitrofurantoin Mono-Macro | 14 | $557 | $40 |
| Ciprofloxacin | 79 | $408 | $5 |
| Hydrocodone-Acetaminophen | 35 | $401 | $11 |
| Terazosin | 11 | $228 | $21 |
| Bicalutamide | 15 | $210 | $14 |
| Cephalexin | 27 | $189 | $7 |
| Sulfamethoxazole-Trimethoprim | 11 | $72 | $7 |
2015: 13 drugs
| Vesicare | 61 | $18,210 | $299 |
| Tamsulosin | 292 | $7,270 | $25 |
| Avodart | 16 | $4,583 | $286 |
| Oxybutynin Chloride Er | 39 | $2,551 | $65 |
| Finasteride | 172 | $1,870 | $11 |
| Oxybutynin Chloride | 45 | $1,602 | $36 |
| Hydrocodone-Acetaminophen | 36 | $367 | $10 |
| Nitrofurantoin Mono-Macro | 13 | $317 | $24 |
| Ciprofloxacin | 54 | $209 | $4 |
| Bicalutamide | 13 | $200 | $15 |
| Terazosin | 13 | $188 | $14 |
| Cephalexin | 22 | $142 | $6 |
| Sulfamethoxazole-Trimethoprim | 11 | $54 | $5 |
2014: 14 drugs
| Vesicare | 40 | $12,048 | $301 |
| Myrbetriq | 13 | $5,044 | $388 |
| Toviaz | 12 | $4,875 | $406 |
| Tamsulosin | 201 | $3,543 | $18 |
| Avodart | 16 | $3,236 | $202 |
| Oxybutynin Chloride | 48 | $1,532 | $32 |
| Nitrofurantoin Mono-Macro | 32 | $1,362 | $43 |
| Finasteride | 118 | $1,239 | $10 |
| Oxybutynin Chloride Er | 12 | $757 | $63 |
| Bicalutamide | 12 | $455 | $38 |
| Hydrocodone-Acetaminophen | 40 | $375 | $9 |
| Ciprofloxacin | 67 | $296 | $4 |
| Terazosin | 15 | $170 | $11 |
| Cephalexin | 19 | $139 | $7 |
2013: 11 drugs
| Vesicare | 39 | $9,911 | $254 |
| Toviaz | 13 | $4,794 | $369 |
| Tamsulosin | 170 | $3,150 | $19 |
| Detrol La | 13 | $2,606 | $200 |
| Finasteride | 81 | $1,642 | $20 |
| Nitrofurantoin Mono-Macro | 28 | $1,567 | $56 |
| Oxybutynin Chloride | 40 | $580 | $14 |
| Hydrocodone-Acetaminophen | 30 | $289 | $10 |
| Ciprofloxacin | 68 | $273 | $4 |
| Cephalexin | 31 | $194 | $6 |
| Sulfamethoxazole-Trimethoprim | 11 | $70 | $6 |
Money from drug and device companies
$173 in 2025
| 2025 | 1 | 1 | None | $173 |
| 2024 | 1 | 3 | None | $690 |
| 2021 | 1 | 3 | $1,250 | $5,400 |
| 2020 | 1 | 4 | None | $8,300 |
| 2019 | 2 | 2 | None | $138 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Spaceoar System | $173 | 1 payment
|
See the published payment
| Boston Scientific | Meals · 2025-06-10 | Spaceoar System | $173 |
See earlier years (2024, 2021, 2020, 2019)
2024: $690
| Edap Technomed | None | $690 | 3 payments
|
2021: $5,400
| Intuitive Surgical | Da Vinci Surgical System | $5,400 | 3 payments
|
2020: $8,300
| Intuitive Surgical | Da Vinci Surgical System | $8,300 | 4 payments
|
2019: $138
| NeoTract | Urolift | $126 | 1 payment
|
| Boston Scientific | Ams | $12 | 1 payment
|
Professional record
- NPI
- 1932221694
- Licence
- CA A86907California A86907: Current · expires 2028-04-30
- Trained
- New York University School of Medicine, 2002
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Urology (208800000X)
- Mailing address
- 2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2007-04-04
- NPI last updated
- 2011-12-12
This is when the NPI record was last certified, not a medical board exam.